Market access pathway
From product uncertainty to regulated launch.
The work starts by defining what the product is, what the market will expect, and which evidence unlocks the next commercial move.
Explore the pathway >01Define the regulated product
Clarify intended purpose, claims, users, clinical context, software boundaries and whether the product is SaMD, AIaMD or adjacent health technology.
02Choose the route to market
Map UK, EU, US and international routes, identify assessment bodies, confirm evidence expectations and sequence work around funding and launch goals.
03Build the evidence system
Create the technical, clinical, risk, software, security, AI governance and quality evidence that supports the chosen route.
04Coordinate specialists
Bring in clinical, security, legal, notified body, FDA, international or implementation specialists where the project needs deeper support.
05Sustain market access
Keep post-market surveillance, change control, security, model monitoring and renewals aligned as the product scales.